Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Improving trends at Nike could drive a re-rating for JD, says Shore Capital

(Sharecast News) - Shares in JD Sports were rising strongly on Friday on the back of hopes of a rebound at Nike, following the American sportswear giant's results released overnight, with Shore Capital showing optimism about positive readacross for the UK retailer. With Nike products representing a significant share of sales at JD, weaker US results at Nike have already been reflected in recent trading at the high street chain, with JD's North American like-for-like sales down 5.5% in the three months to end of April.

Nevertheless, while Nike's full-year revenues were down 10%, sales for its fourth quarter to end-May were comfortably ahead of market forecasts.

"While there is clearly still work to be done on Nike's recovery, the company expects an improving trend in the first quarter to just mid-single digit revenue decline. This is expected to be particularly driven by the challenging Chinese market which is expected to take longer to return to growth, while Nike sees better momentum in the US and Europe," said Shore Capital analyst David Hughes.

While the brand continues to struggle in its D2C business, the view on wholesale partners like JD is more optimistic, with an improving order book and growth in seasonal orders, Hughes said.

"Overall, the double-digit sales decline for Nike has undoubtedly been a significant headwind for JD and there is still more work to do before the company sees a return to revenue growth and in continuing to clean the inventory position. However, with this update we do see early signs of an improving wholesale channel. Such an improvement in wholesale (particularly in the US) is key for JD's to see a return to American growth."

A return to LFL growth in the US should drive a re-rating in JD's stock.

Shares were up 6.5% at 87.04p by 0959 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.